Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Xiaoxi, Xie"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Toripalimab (Junshi Bioscience Co., Ltd) is a new immune checkpoint inhibitor (ICI) that targets programmed cell death protein 1 (PD-1) in various cancers, including metastatic melanoma. No neurological immune-related adverse events (n-irAEs) of tori
Externí odkaz:
https://doaj.org/article/9af2043b8550413aa09dfbed00c0a28a
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
We report the case of a 47-year-old male patient with pigmentation of the head, face and hands, who was initially diagnosed as having primary adrenal insufficiency (Addison’s disease). Laboratory testing, imaging and physical examination revealed s
Externí odkaz:
https://doaj.org/article/870836cbf8c54a2bac3785d10af75d5e
Autor:
Chengyi Li, Xiusong Zhu, Juxian Chen, Xiaoxi Xie, Sijia Liang, Xiu Liu, Quan Gong, Jiawei Guo
Publikováno v:
Acta Biochimica et Biophysica Sinica. 55:183-193
Autor:
Qinming Hou, Wenhao Hu, Zhichao Sun, Wenbin Ji, Xia Wu, Ling Li, Tiefeng Li, Wenqiang Yu, Jian Zhou, Zhiyi Peng, Huanhai Xu, Guohong Cao, Yutang Chen, Jun Han, Wenjiang Gu, Xin Zhang, Jun-Hui Sun, Jiansong Ji, Hongjie Hu, Haijun Du, Jing Huang, Tingyang Hu, Xiaoxi Xie, Shihong Ying, Guoliang Shao, Xiaohua Guo, Dedong Zhu, Jian Fang, Guan-Hui Zhou, Jiaping Zheng, Jun Luo, Changsheng Shi, Zhihai Yu
Publikováno v:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28:249-271
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver cancer. A total of 367 liver cancer patients from 24 medical centers
Autor:
Jiansong Ji, Hongjie Hu, Wenjiang Gu, Wenhao Hu, Ling Li, Zhichao Sun, Xiaoxi Xie, Qinming Hou, Zhiyi Peng, Huanhai Xu, Xiaohua Guo, Shihong Ying, Dedong Zhu, Jun Han, Tingyang Hu, Changsheng Shi, Jian Zhou, Wenqiang Yu, Tiefeng Li, Xin Zhang, Jing Huang, Haijun Du, Yutang Chen, Guohong Cao, Jun-Hui Sun, Zhihai Yu, Guoliang Shao, Guan-Hui Zhou, Xia Wu, Wenbin Ji, Jian Fang, Jun Luo, Jiaping Zheng
Publikováno v:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28:75-94
The purpose of this study was to investigate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) treatment in Chinese hepatocellular carcinoma (HCC) patients and the prognostic factors for treatment response as we
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 227
Vitamin D receptor (VDR) and SLC26A3 (DRA) have been identified as pivotal protective factors in maintaining gut homeostasis in IBD patients. However, the specific mechanism underlying the increased intestinal susceptibility to inflammation induced b
Autor:
Xia Wu, Shihong Ying, Jing Huang, Changsheng Shi, Jiansong Ji, Zhiyi Peng, Guanhui Zhou, Zhichao Sun, Junhui Sun, Wenqiang Yu, Wenhao Hu, Xin Zhang, Jian Zhou, Guoliang Shao, Zhihai Yu, Qinming Hou, Wenjiang Gu, Tiefeng Li, Xiaoxi Xie, Guohong Cao, Haijun Du, Dedong Zhu, Huanhai Xu, Jun Han, Wenbin Ji, Jian Fang, Ling Li, Jiaping Zheng, Jun Luo, Yutang Chen, Tingyang Hu, Hongjie Hu, Xiaohua Guo
Publikováno v:
Translational Cancer Research
Background This study aimed to assess the treatment response, short-term overall survival (OS) and safety profiles of drug-eluting beads transarterial chemoembolization (DEB-TACE) in patients with secondary liver cancer. Methods Fifty-five patients w
Publikováno v:
Peptides. 151:170753
The intestinal barrier is a dynamic entity that is organized as a multilayer system and includes various intracellular and extracellular elements. The gut barrier functions in a coordinated manner to impede the passage of antigens, toxins, and microb
Autor:
Zhiyi, Peng, Guohong, Cao, Qinming, Hou, Ling, Li, Shihong, Ying, Junhui, Sun, Guanhui, Zhou, Jian, Zhou, Xin, Zhang, Wenbin, Ji, Zhihai, Yu, Tiefeng, Li, Dedong, Zhu, Wenhao, Hu, Jiansong, Ji, Haijun, Du, Changsheng, Shi, Xiaohua, Guo, Jian, Fang, Jun, Han, Wenjiang, Gu, Xiaoxi, Xie, Zhichao, Sun, Huanhai, Xu, Xia, Wu, Tingyang, Hu, Jing, Huang, Hongjie, Hu, Jiaping, Zheng, Jun, Luo, Yutang, Chen, Wenqiang, Yu, Guoliang, Shao
Publikováno v:
Oncology Research
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver cancer. A total of 367 liver cancer patients from 24 medical centers
Autor:
Junhui, Sun, Guanhui, Zhou, Xiaoxi, Xie, Wenjiang, Gu, Jing, Huang, Dedong, Zhu, Wenhao, Hu, Qinming, Hou, Changsheng, Shi, Tiefeng, Li, Xin, Zhang, Wenbin, Ji, Shihong, Ying, Zhiyi, Peng, Jian, Zhou, Zhihai, Yu, Jiansong, Ji, Haijun, Du, Xiaohua, Guo, Jian, Fang, Jun, Han, Huanhai, Xu, Zhichao, Sun, Wenqiang, Yu, Guoliang, Shao, Xia, Wu, Hongjie, Hu, Ling, Li, Jiaping, Zheng, Jun, Luo, Yutang, Chen, Guohong, Cao, Tingyang, Hu
Publikováno v:
Oncology Research
The purpose of this study was to investigate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) treatment in Chinese hepatocellular carcinoma (HCC) patients and the prognostic factors for treatment response as we